This session will focus on the unique challenges companies face when using agile on projects that involve FDA governance: large company conservative culture, regulatory documentation, requirements tracing, and a bias towards waterfall development. Skeptics argue that agile is best suited to small- and medium-sized companies and wrongly perceive agile as a limited, negating its use … Continued

You must be a Member to view this post and you are currently not logged in.

You can either log in below or sign up here.